🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate the efficacy and safety of AK104 plus concurrent ...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2022-06-21
Trial ID
NCT05235516
A Phase II Study Evaluating the Efficacy and Safety of LM-302 in Combinatio...
Status
Recruiting
Location
Zhongshan Hospital Fudan University
Start Date
2024-07-31
Trial ID
NCT06587425
Treatments Being Tested
This is a multicenter, open-label, phase II clinical study conducted in Chi...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2021-04-01
Trial ID
NCT04868708
Treatments Being Tested
A Phase Ia/Ib open label，clinical study evaluating the safety, tolerability...
Status
Recruiting
Location
Tianjin Cancer Hospital
Start Date
2023-06-29
Trial ID
NCT05868876
Treatments Being Tested
This study is an exploratory clinical trial to investigate the feasibility ...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-09-03
Trial ID
NCT06289751
This is a prospective, single-arm, open-label，single-center, phase II study...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2023-03-21
Trial ID
NCT05853172
Treatments Being Tested
The advent of immunotherapy has changed the treatment landscape for patient...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-21
Trial ID
NCT06946836
Treatments Being Tested
This is a first-in-human (FIH), Phase 1a/1b, Multicenter, Open-Label, Dose-...
Status
Completed
Location
Blacktown Cancer and Haematology Centre (Blacktown Hospital)
Start Date
2020-12-07
Trial ID
NCT04572152
The goal of this clinical trial is to investigate the efficacy, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06620796
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of Cadonilim...
Status
Not Yet Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2024-02-10
Trial ID
NCT06202313
Treatments Being Tested